| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The association of minocycline and the probiotic Escherichia coli Nissle 1917 results in an additive beneficial effect in a DSS model of reactivated colitis in mice. | Biochem Pharmacol | 2011 | 0.93 |
| 2 | Butyrate in vitro immune-modulatory effects might be mediated through a proliferation-related induction of apoptosis. | Immunobiology | 2010 | 0.92 |
| 3 | The probiotic Lactobacillus coryniformis CECT5711 reduces the vascular pro-oxidant and pro-inflammatory status in obese mice. | Clin Sci (Lond) | 2014 | 0.91 |
| 4 | The intestinal anti-inflammatory effect of minocycline in experimental colitis involves both its immunomodulatory and antimicrobial properties. | Pharmacol Res | 2010 | 0.85 |